Rare diseases
Investigational molecules
Locations
706 conditions with trials, the busiest first
3 926 trials across Europe, recruiting first
CroatiaStudy on Advanced Liver Cancer: Evaluating Livmoniplimab and Budigalimab in Patients Without Prior Systemic Treatment
FranceStudy of nivolumab, relatlimab and bevacizumab combination for patients with untreated advanced or metastatic liver cancer (hepatocellular carcinoma)
FranceStudy of Datopotamab Deruxtecan and Pembrolizumab for Patients with Advanced or Metastatic Non-small Cell Lung Cancer Without Actionable Genomic Alterations
AustriaStudy of BT5528 alone and with nivolumab in patients with advanced solid tumors that have EphA2 protein expression
BelgiumStudy on Atezolizumab for Patients with Non-Small Cell Lung Cancer After Chemotherapy
FranceStudy of Mosunetuzumab and Drug Combination for Untreated Patients with Richter's Syndrome
SpainStudy of Sotorasib Treatment in Patients with Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) with KRAS G12C Mutation Who Have Previously Received Treatment
FranceStudy of Niraparib and Dostarlimab for Children with Recurrent or Hard-to-Treat Solid Tumors
CzechiaStudy of Pembrolizumab, Olaparib, and Pemetrexed for Patients with Stage IV Non-Small Cell Lung Cancer
AustriaStudy on the Effectiveness of Carboplatin and Olaparib for Patients with Triple-Negative Breast Cancer with Positive HRD Status
AustriaStudy on Epcoritamab, Rituximab, and Lenalidomide for Adults with Untreated Follicular Lymphoma
BelgiumThe therapies tested most often in Neoplasms benign, malignant and unspecified (incl cysts and polyps) trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
